The global Apigeninidin market size was valued at US$ million in 2023. With growing demand in downstream market, the Apigeninidin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Apigeninidin market. Apigeninidin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Apigeninidin. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Apigeninidin market.
Apigeninidin (Also, apigenidin,or Gesneridin) is a chemical compound belonging to the 3-deoxyanthocyanidins and that can be found in the Patagonian plant Ephedra frustillata and in the soybean. Apigeninidin is one of the principal pigments found in sorghum. Extremely high level of apigeninidin (49 mg/g) has been documented in sorghum leaf sheath. Like all anthocyanidins it exists in a variety of tautomers depending on pH and hydration, several of these bare the distinctive pyrylium core.Apigenin is a protein kinase inhibitor. Suppresses tumor-promoting effects of TPA and exhibits antiproliferative activity in human breast cancer cells (IC50 values are 59.44 and 31.15 渭M at 24 and 72 hrs respectively). Activates both the intrinsic and extrinsic apoptotic pathways and displays anti-inflammatory, hypotensive, antispasmodic and antioxidant properties in vivo.Apigenin, found in many plants, is a natural product belonging to the flavone class that is the aglycone of several naturally-occurring glycosides. Apigenin acts as a monoamine transporter activator, one of the few chemicals demonstrated to possess this property. Apigenin is a ligand for central benzodiazepine receptors that competitively inhibited the binding of flunitrazepam with a Ki of 4渭M, exerting anxiolytic and slight sedative effects.
Key Features:
The report on Apigeninidin market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Apigeninidin market. It may include historical data, market segmentation by Type (e.g., Powder, Crystalline Solid), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Apigeninidin market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Apigeninidin market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Apigeninidin industry. This include advancements in Apigeninidin technology, Apigeninidin new entrants, Apigeninidin new investment, and other innovations that are shaping the future of Apigeninidin.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Apigeninidin market. It includes factors influencing customer ' purchasing decisions, preferences for Apigeninidin product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Apigeninidin market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Apigeninidin market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Apigeninidin market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Apigeninidin industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Apigeninidin market.
Market Segmentation:
Apigeninidin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Powder
Crystalline Solid
Others
Segmentation by application
Food Industry
Medical Care
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-techne
Creative Enzymes
MedChemExpress
Biosynth Carbosynth
United States Biological
Molekula
BOC Sciences
FoodChem
Focus Biomolecules
Ottokemi
BioCrick
Lanyor
NEO Biotech
ChemFaces
Cayman
Sigma-Aldrich
Key Questions Addressed in this Report
What is the 10-year outlook for the global Apigeninidin market?
What factors are driving Apigeninidin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Apigeninidin market opportunities vary by end market size?
How does Apigeninidin break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Apigeninidin Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Apigeninidin by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Apigeninidin by Country/Region, 2019, 2023 & 2030
2.2 Apigeninidin Segment by Type
2.2.1 Powder
2.2.2 Crystalline Solid
2.2.3 Others
2.3 Apigeninidin Sales by Type
2.3.1 Global Apigeninidin Sales Market Share by Type (2019-2024)
2.3.2 Global Apigeninidin Revenue and Market Share by Type (2019-2024)
2.3.3 Global Apigeninidin Sale Price by Type (2019-2024)
2.4 Apigeninidin Segment by Application
2.4.1 Food Industry
2.4.2 Medical Care
2.4.3 Scientific Research
2.4.4 Others
2.5 Apigeninidin Sales by Application
2.5.1 Global Apigeninidin Sale Market Share by Application (2019-2024)
2.5.2 Global Apigeninidin Revenue and Market Share by Application (2019-2024)
2.5.3 Global Apigeninidin Sale Price by Application (2019-2024)
3 Global Apigeninidin by Company
3.1 Global Apigeninidin Breakdown Data by Company
3.1.1 Global Apigeninidin Annual Sales by Company (2019-2024)
3.1.2 Global Apigeninidin Sales Market Share by Company (2019-2024)
3.2 Global Apigeninidin Annual Revenue by Company (2019-2024)
3.2.1 Global Apigeninidin Revenue by Company (2019-2024)
3.2.2 Global Apigeninidin Revenue Market Share by Company (2019-2024)
3.3 Global Apigeninidin Sale Price by Company
3.4 Key Manufacturers Apigeninidin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Apigeninidin Product Location Distribution
3.4.2 Players Apigeninidin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Apigeninidin by Geographic Region
4.1 World Historic Apigeninidin Market Size by Geographic Region (2019-2024)
4.1.1 Global Apigeninidin Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Apigeninidin Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Apigeninidin Market Size by Country/Region (2019-2024)
4.2.1 Global Apigeninidin Annual Sales by Country/Region (2019-2024)
4.2.2 Global Apigeninidin Annual Revenue by Country/Region (2019-2024)
4.3 Americas Apigeninidin Sales Growth
4.4 APAC Apigeninidin Sales Growth
4.5 Europe Apigeninidin Sales Growth
4.6 Middle East & Africa Apigeninidin Sales Growth
5 Americas
5.1 Americas Apigeninidin Sales by Country
5.1.1 Americas Apigeninidin Sales by Country (2019-2024)
5.1.2 Americas Apigeninidin Revenue by Country (2019-2024)
5.2 Americas Apigeninidin Sales by Type
5.3 Americas Apigeninidin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Apigeninidin Sales by Region
6.1.1 APAC Apigeninidin Sales by Region (2019-2024)
6.1.2 APAC Apigeninidin Revenue by Region (2019-2024)
6.2 APAC Apigeninidin Sales by Type
6.3 APAC Apigeninidin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Apigeninidin by Country
7.1.1 Europe Apigeninidin Sales by Country (2019-2024)
7.1.2 Europe Apigeninidin Revenue by Country (2019-2024)
7.2 Europe Apigeninidin Sales by Type
7.3 Europe Apigeninidin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Apigeninidin by Country
8.1.1 Middle East & Africa Apigeninidin Sales by Country (2019-2024)
8.1.2 Middle East & Africa Apigeninidin Revenue by Country (2019-2024)
8.2 Middle East & Africa Apigeninidin Sales by Type
8.3 Middle East & Africa Apigeninidin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Apigeninidin
10.3 Manufacturing Process Analysis of Apigeninidin
10.4 Industry Chain Structure of Apigeninidin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Apigeninidin Distributors
11.3 Apigeninidin Customer
12 World Forecast Review for Apigeninidin by Geographic Region
12.1 Global Apigeninidin Market Size Forecast by Region
12.1.1 Global Apigeninidin Forecast by Region (2025-2030)
12.1.2 Global Apigeninidin Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Apigeninidin Forecast by Type
12.7 Global Apigeninidin Forecast by Application
13 Key Players Analysis
13.1 Bio-techne
13.1.1 Bio-techne Company Information
13.1.2 Bio-techne Apigeninidin Product Portfolios and Specifications
13.1.3 Bio-techne Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bio-techne Main Business Overview
13.1.5 Bio-techne Latest Developments
13.2 Creative Enzymes
13.2.1 Creative Enzymes Company Information
13.2.2 Creative Enzymes Apigeninidin Product Portfolios and Specifications
13.2.3 Creative Enzymes Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Creative Enzymes Main Business Overview
13.2.5 Creative Enzymes Latest Developments
13.3 MedChemExpress
13.3.1 MedChemExpress Company Information
13.3.2 MedChemExpress Apigeninidin Product Portfolios and Specifications
13.3.3 MedChemExpress Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 MedChemExpress Main Business Overview
13.3.5 MedChemExpress Latest Developments
13.4 Biosynth Carbosynth
13.4.1 Biosynth Carbosynth Company Information
13.4.2 Biosynth Carbosynth Apigeninidin Product Portfolios and Specifications
13.4.3 Biosynth Carbosynth Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Biosynth Carbosynth Main Business Overview
13.4.5 Biosynth Carbosynth Latest Developments
13.5 United States Biological
13.5.1 United States Biological Company Information
13.5.2 United States Biological Apigeninidin Product Portfolios and Specifications
13.5.3 United States Biological Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 United States Biological Main Business Overview
13.5.5 United States Biological Latest Developments
13.6 Molekula
13.6.1 Molekula Company Information
13.6.2 Molekula Apigeninidin Product Portfolios and Specifications
13.6.3 Molekula Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Molekula Main Business Overview
13.6.5 Molekula Latest Developments
13.7 BOC Sciences
13.7.1 BOC Sciences Company Information
13.7.2 BOC Sciences Apigeninidin Product Portfolios and Specifications
13.7.3 BOC Sciences Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 BOC Sciences Main Business Overview
13.7.5 BOC Sciences Latest Developments
13.8 FoodChem
13.8.1 FoodChem Company Information
13.8.2 FoodChem Apigeninidin Product Portfolios and Specifications
13.8.3 FoodChem Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 FoodChem Main Business Overview
13.8.5 FoodChem Latest Developments
13.9 Focus Biomolecules
13.9.1 Focus Biomolecules Company Information
13.9.2 Focus Biomolecules Apigeninidin Product Portfolios and Specifications
13.9.3 Focus Biomolecules Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Focus Biomolecules Main Business Overview
13.9.5 Focus Biomolecules Latest Developments
13.10 Ottokemi
13.10.1 Ottokemi Company Information
13.10.2 Ottokemi Apigeninidin Product Portfolios and Specifications
13.10.3 Ottokemi Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Ottokemi Main Business Overview
13.10.5 Ottokemi Latest Developments
13.11 BioCrick
13.11.1 BioCrick Company Information
13.11.2 BioCrick Apigeninidin Product Portfolios and Specifications
13.11.3 BioCrick Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 BioCrick Main Business Overview
13.11.5 BioCrick Latest Developments
13.12 Lanyor
13.12.1 Lanyor Company Information
13.12.2 Lanyor Apigeninidin Product Portfolios and Specifications
13.12.3 Lanyor Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Lanyor Main Business Overview
13.12.5 Lanyor Latest Developments
13.13 NEO Biotech
13.13.1 NEO Biotech Company Information
13.13.2 NEO Biotech Apigeninidin Product Portfolios and Specifications
13.13.3 NEO Biotech Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 NEO Biotech Main Business Overview
13.13.5 NEO Biotech Latest Developments
13.14 ChemFaces
13.14.1 ChemFaces Company Information
13.14.2 ChemFaces Apigeninidin Product Portfolios and Specifications
13.14.3 ChemFaces Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 ChemFaces Main Business Overview
13.14.5 ChemFaces Latest Developments
13.15 Cayman
13.15.1 Cayman Company Information
13.15.2 Cayman Apigeninidin Product Portfolios and Specifications
13.15.3 Cayman Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Cayman Main Business Overview
13.15.5 Cayman Latest Developments
13.16 Sigma-Aldrich
13.16.1 Sigma-Aldrich Company Information
13.16.2 Sigma-Aldrich Apigeninidin Product Portfolios and Specifications
13.16.3 Sigma-Aldrich Apigeninidin Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Sigma-Aldrich Main Business Overview
13.16.5 Sigma-Aldrich Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
